Greg Lazar
Director and Senior Scientist, Antibody Engineering
"Be the ball."
My scientific background is in protein folding, protein design, structural biology, and antibody engineering. I am blessed with the opportunity to do research and drug discovery at such an innovative leader in antibody therapeutics. Every day at Genentech I work with an army of extraordinarily talented colleagues to drive biotherapeutic innovation and tackle life's most difficult diseases.
Postdoctoral Mentor
Genentech's postdoc program is a great example of how committed we are to basic science, and I consider it a privilege to be a mentor in this program. With the backing of tremendous laboratory resources, postdocs here are encouraged to explore the most important and challenging problems, regardless of how distal the science is to our drug pipeline. In many respects this is why postdocs are so valuable to Genentech, because it effectively commits incredible intellectual horsepower to explore original research directions and open new doors to innovation. It is a great formula for enabling future generations of biotech medicines.
Featured Publication
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members.
MAbs, 2019, 11(6):996-1011.